Last Updated: 14 Nov 2024
Executive Summary
ICON PLC (ICLR) is a global clinical research organization that provides outsourced marketing and development services. The company has a strong financial performance with a market capitalization of $17.5 billion, EBITDA of $1.68 billion, and EPS of $8.99. ICON PLC has a positive outlook with analyst target price of $287.65 and a consensus rating of "Buy."
Company Overview
ICON PLC is headquartered in Dublin, Ireland and has operations in over 50 countries. The company provides a wide range of clinical research services, including clinical trial design, conduct, and analysis; data management; and regulatory affairs. ICON PLC has a strong track record of success, having conducted over 1,000 clinical trials for over 200 clients.
Fundamental Analysis
ICON PLC has a strong financial position with a healthy balance sheet and strong cash flow. The company's revenue has grown steadily in recent years, and is expected to continue to grow in the future. ICON PLC's profit margin is also healthy, and is expected to remain stable in the future. The company's ROE and ROA are also healthy, indicating that the company is using its assets efficiently.
Technical Analysis
ICON PLC's stock price has been trending down in recent months, but is now starting to show signs of a reversal. The stock is currently trading above its 50-day moving average, and is approaching its 200-day moving average. The RSI is also showing signs of a bullish divergence, which is a positive sign.
Short Term Outlook
ICON PLC's stock price is expected to continue to rise in the short term. The stock is currently trading at a discount to its analyst target price, and is expected to reach its target price in the next 12 months.
Long Term Outlook
ICON PLC's long term outlook is also positive. The company is expected to continue to grow its revenue and earnings in the future. The company's strong financial position and track record of success make it well-positioned to continue to grow in the future.
Analyst Recommendations
The consensus analyst rating for ICON PLC is "Buy." The average analyst target price is $287.65, which represents a potential upside of 41% from the current price. Seven analysts have a "Strong Buy" rating on the stock, 10 analysts have a "Buy" rating, and 2 analysts have a "Hold" rating. No analysts have a "Sell" or "Strong Sell" rating on the stock.
